Lantronix, Inc. (LTRX) Posts Q3 Loss of 3c/Share
Tweet
Share
E-mailGet Alerts LTRX Hot Sheet
Price: $6.17 --0%
Financial Fact:
Research and development: 1.95M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Research and development: 1.95M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Lantronix, Inc. (NASDAQ: LTRX) reported Q3 EPS of ($0.03), $0.01 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $12.2 million versus the consensus estimate of $12.4 million.
For earnings history and earnings-related data on Lantronix, Inc. (LTRX) click here.
For earnings history and earnings-related data on Lantronix, Inc. (LTRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- BK Technologies (BKTI) Tops Q2 EPS by 11c
- Pyxis Oncology, Inc. (PYXS) Misses Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
